-
1
-
-
0026323802
-
Results of therapy for acute myeloid leukemia in first relapse
-
Angelov, L., Brandwein, J.M. & Baker, M.A. (1991) Results of therapy for acute myeloid leukemia in first relapse. Leukemia and Lymphoma, 6, 15-19.
-
(1991)
Leukemia and Lymphoma
, vol.6
, pp. 15-19
-
-
Angelov, L.1
Brandwein, J.M.2
Baker, M.A.3
-
2
-
-
0030665228
-
Long-term survival after chemotherapy for acute myeloid leukemia: The experience of the Southwest Oncology Group
-
Appelbaum, F.R. & Kopecky, K.J. (1997) Long-term survival after chemotherapy for acute myeloid leukemia: the experience of the Southwest Oncology Group. Cancer. 80, (Suppl.), 2199-2204.
-
(1997)
Cancer
, vol.80
, Issue.SUPPL.
, pp. 2199-2204
-
-
Appelbaum, F.R.1
Kopecky, K.J.2
-
3
-
-
0028801482
-
Timed sequential chemotherapy for previously treated patients with acute mycloid leukemia: Long-term follow-up of etoposide, mitoxantrone and cytarahine; 86 trial
-
Archimbaud, E., Thomas, X., Leblond, V., Michallet, M., Fenaux, P., Cordonnier, C., Dreyfus, K. Troussard, X., Jaubert, J. & Travade, P. (1995) Timed sequential chemotherapy for previously treated patients with acute mycloid leukemia: long-term follow-up of etoposide, mitoxantrone and cytarahine; 86 trial. Journal of Clinical Oncology. 13, 11-18.
-
(1995)
Journal of Clinical Oncology
, vol.13
, pp. 11-18
-
-
Archimbaud, E.1
Thomas, X.2
Leblond, V.3
Michallet, M.4
Fenaux, P.5
Cordonnier, C.6
Dreyfus, K.7
Troussard, X.8
Jaubert, J.9
Travade, P.10
-
4
-
-
0025275742
-
Randomised multi-center trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL)
-
Arlin, Z., Case, D.C., Moore, J., Wiernik, P., Feldman, E., Saletan, S., Desai, P., Sai, L., & Cartwright, K., (1990) Randomised multi-center trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Leukemia. 4, 177-183.
-
(1990)
Leukemia
, vol.4
, pp. 177-183
-
-
Arlin, Z.1
Case, D.C.2
Moore, J.3
Wiernik, P.4
Feldman, E.5
Saletan, S.6
Desai, P.7
Sai, L.8
Cartwright, K.9
-
5
-
-
0032558759
-
Treatment of high risk acute leukemia with T cell depleted sterm cells from related donors with one fully mismatched HLA haplotype
-
Aversa, E., Tabilio, A., Velardi, A., Cunningham, L., Terenzi, A., Falzetti, F., Ruggeri, L., Barbabietola, G., Aristei, C., Latini, P., Reisner, Y., & Martelli, M.F. (1998) Treatment of high risk acute leukemia with T cell depleted sterm cells from related donors with one fully mismatched HLA haplotype. New England Journal of Medicine. 339, 1186-1193.
-
(1998)
New England Journal of Medicine
, vol.339
, pp. 1186-1193
-
-
Aversa, E.1
Tabilio, A.2
Velardi, A.3
Cunningham, L.4
Terenzi, A.5
Falzetti, F.6
Ruggeri, L.7
Barbabietola, G.8
Aristei, C.9
Latini, P.10
Reisner, Y.11
Martelli, M.F.12
-
6
-
-
0028945145
-
Relapsing acute myeloid leukemia manifesting as hypopyon uveitis
-
Avliffe, W., Foster, C.S., Marcoux, P., Upton, M., Finkelstein, M., Kuperwaser, M. & Legman, A. (1995) Relapsing acute myeloid leukemia manifesting as hypopyon uveitis. American Journal of Opthalmology. 119, 361-364.
-
(1995)
American Journal of Opthalmology
, vol.119
, pp. 361-364
-
-
Avliffe, W.1
Foster, C.S.2
Marcoux, P.3
Upton, M.4
Finkelstein, M.5
Kuperwaser, M.6
Legman, A.7
-
7
-
-
0026340666
-
Second transplants for leukaemic relapse after bone marrow transplantation: High early mortality but favourable effect of chronic GvHD on continued remission. A report by the EBMT Leukaemia Working Party
-
Barrett, A.J., Locatelli, E., Treleaven, J.G., Gratwohl, A., Szyldo, R. & Zwaan, F.E. (1991) Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GvHD on continued remission. A report by the EBMT Leukaemia Working Party. British Journal of Haematology. 79, 567-574.
-
(1991)
British Journal of Haematology
, vol.79
, pp. 567-574
-
-
Barrett, A.J.1
Locatelli, E.2
Treleaven, J.G.3
Gratwohl, A.4
Szyldo, R.5
Zwaan, F.E.6
-
8
-
-
0025907179
-
Results of a randomised trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia
-
Berman, E., Raymond, Z., Daghestani, A., Arlin, Z.A., Gee, T.S., Kempin, S., Hancock, C., Williams, L., Stevens, Y.W., Clarkson, B.D., & Young, C. (1991) Results of a randomised trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. Blood, 77, 1666-1674.
-
(1991)
Blood
, vol.77
, pp. 1666-1674
-
-
Berman, E.1
Raymond, Z.2
Daghestani, A.3
Arlin, Z.A.4
Gee, T.S.5
Kempin, S.6
Hancock, C.7
Williams, L.8
Stevens, Y.W.9
Clarkson, B.D.10
Young, C.11
-
9
-
-
15644380236
-
Long-term survival of patients with acute myeloid leukemia: A third follow-up of the Fourth International Workshop on Chromosomes in Leukemia
-
Bloomfield, CD., Shuma, C., Regal, L., Philip, P.P., Hossfeld, D.K., Hagemeijer, A.M., Garson, O.M., Peterson, B.A., Sakurai, M., Alimena, G., Berger, R., Rowley, J.D., Ruutu, T., Mitelman, F., Dewald, G.W. & Swansbury, J. (1997) Long-term survival of patients with acute myeloid leukemia: a third follow-up of the Fourth International Workshop on Chromosomes in Leukemia, Cancer, 80. (Suppl.), 2191-2198.
-
(1997)
Cancer
, vol.80
, Issue.SUPPL.
, pp. 2191-2198
-
-
Bloomfield, C.D.1
Shuma, C.2
Regal, L.3
Philip, P.P.4
Hossfeld, D.K.5
Hagemeijer, A.M.6
Garson, O.M.7
Peterson, B.A.8
Sakurai, M.9
Alimena, G.10
Berger, R.11
Rowley, J.D.12
Ruutu, T.13
Mitelman, F.14
Dewald, G.W.15
Swansbury, J.16
-
10
-
-
16944363396
-
Second allogeneic: Bone marrow transplantation in acute leukemia: A multicenter study from the Gruppo Italiano Trapianto di Midollo Osseo
-
Bosi, A., Bacci, S., Miniero, R., Locatelli, F., Laszlo, D., Longo, G., Busca, A., van Lint, M.T., Di Bartolomeo, P. & Amici, A. (1997) Second allogeneic: bone marrow transplantation in acute leukemia: a multicenter study from the Gruppo Italiano Trapianto di Midollo Osseo. Leukemia, 11, 420-424.
-
(1997)
Leukemia
, vol.11
, pp. 420-424
-
-
Bosi, A.1
Bacci, S.2
Miniero, R.3
Locatelli, F.4
Laszlo, D.5
Longo, G.6
Busca, A.7
Van Lint, M.T.8
Di Bartolomeo, P.9
Amici, A.10
-
11
-
-
0028920312
-
High dose etoposide, cyclophosphamide and total body irradiation with bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: A study by the North American marrow transplant group
-
Brown, R.A., Wolff, S.N., Fay, J.W., Pinicro, L., Collins, R.H., Lynch, J.P., Stevens, D., Greer, J., Herzig, R.M. & Herzig, G.P. (1995) High dose etoposide, cyclophosphamide and total body irradiation with bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American marrow transplant group. Blood, 85, 1391-1395.
-
(1995)
Blood
, vol.85
, pp. 1391-1395
-
-
Brown, R.A.1
Wolff, S.N.2
Fay, J.W.3
Pinicro, L.4
Collins, R.H.5
Lynch, J.P.6
Stevens, D.7
Greer, J.8
Herzig, R.M.9
Herzig, G.P.10
-
12
-
-
10144257875
-
High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: A study by the North American Marrow Transplant Group
-
Brown, R.A., Wolff, S.N., Fay, J.W., Pineiro, L. Collins, R.H., Lynch, J.P., Stevens, D., Greer, J., Herzig, R.H., & Herzig, G.P. (1996) High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant Group. Leukemia and Lymphoma, 22, 271-277.
-
(1996)
Leukemia and Lymphoma
, vol.22
, pp. 271-277
-
-
Brown, R.A.1
Wolff, S.N.2
Fay, J.W.3
Pineiro, L.4
Collins, R.H.5
Lynch, J.P.6
Stevens, D.7
Greer, J.8
Herzig, R.H.9
Herzig, G.P.10
-
13
-
-
0029918790
-
The role of prognostic factors in acute myeloid leukemia
-
Buchmer, T. & Heinecke, A. (1996) The role of prognostic factors in acute myeloid leukemia. Leukemia, 10, (Suppl. 1), S28-S29.
-
(1996)
Leukemia
, vol.10
, Issue.SUPPL. 1
-
-
Buchmer, T.1
Heinecke, A.2
-
14
-
-
0026048743
-
Recombinant human granulocyte-macrophage stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapse
-
Buchner, T., Hiddemann, W., Koenigsmann, M., Zuhlsdorf, M., Wormann, B., Boeckmann, A., Freire, E.A., Innig, G., Maschmeyer, G., Ludwig, W.D., Sauerland, M.C., Heineck, A. & Schulz, G. (1991) Recombinant human granulocyte-macrophage stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapse. Blood. 78, 1190-1192.
-
(1991)
Blood
, vol.78
, pp. 1190-1192
-
-
Buchner, T.1
Hiddemann, W.2
Koenigsmann, M.3
Zuhlsdorf, M.4
Wormann, B.5
Boeckmann, A.6
Freire, E.A.7
Innig, G.8
Maschmeyer, G.9
Ludwig, W.D.10
Sauerland, M.C.11
Heineck, A.12
Schulz, G.13
-
15
-
-
85031441016
-
Definition and prognostic system in two sequential studies by the German AML cooperative group
-
Buchner, T., Hiddemann, W., Wormann, B., Loffler, H., Gassmann, W., Haferlach, T., Fonatsch, C., Hasse, D., Schoch, C., Hossfeld, D., Lengfelder, E., Aul, C., Heyll, A., Maschmeyer, G., Ludwig, W.-D., Staib, P., Sauerland, M.-C. & Heinecke, A. (1998) Definition and prognostic system in two sequential studies by the German AML cooperative group. Blood, 92, (Suppl. 1). 230a.
-
(1998)
Blood
, vol.92
, Issue.SUPPL. 1
-
-
Buchner, T.1
Hiddemann, W.2
Wormann, B.3
Loffler, H.4
Gassmann, W.5
Haferlach, T.6
Fonatsch, C.7
Hasse, D.8
Schoch, C.9
Hossfeld, D.10
Lengfelder, E.11
Aul, C.12
Heyll, A.13
Maschmeyer, G.14
Ludwig, W.-D.15
Staib, P.16
Sauerland, M.-C.17
Heinecke, A.18
-
16
-
-
0032492441
-
Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: Results of MRC AMT, 10 trial
-
Burnett, A.K., Goldstone, A.H., Stevens, R.M.F., Hann, I.M., Rees, J.K.H., Gray, R.G. & Wheatley, K. (1998) Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AMT, 10 trial. Lancet. 351, 700-707.
-
(1998)
Lancet
, vol.351
, pp. 700-707
-
-
Burnett, A.K.1
Goldstone, A.H.2
Stevens, R.M.F.3
Hann, I.M.4
Rees, J.K.H.5
Gray, R.G.6
Wheatley, K.7
-
17
-
-
0028905531
-
Detection of minimal residual disease in acute leukemia: Methodologic advances and clinical significance
-
Campana, D. & Pui, C.H. (1995) Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood. 85, 1416-1434.
-
(1995)
Blood
, vol.85
, pp. 1416-1434
-
-
Campana, D.1
Pui, C.H.2
-
18
-
-
0021341818
-
Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginase
-
Capizzi, R.L., Poole, M., Cooper, M.R., Richards, E., Stuart, J.J., Jackson, D.V., White, D.R., Spurr, C.L., Hopkins. J.O., Muss, H.B., Rudnick, S.A., Wells, R., Gabriel, D. & Ross. D. (1984) Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginase. Blood, 63, 694-700.
-
(1984)
Blood
, vol.63
, pp. 694-700
-
-
Capizzi, R.L.1
Poole, M.2
Cooper, M.R.3
Richards, E.4
Stuart, J.J.5
Jackson, D.V.6
White, D.R.7
Spurr, C.L.8
Hopkins, J.O.9
Muss, H.B.10
Rudnick, S.A.11
Wells, R.12
Gabriel, D.13
Ross, D.14
-
19
-
-
0030610686
-
Use of arsenic trioxide (AS203) in the treatment of acute promyelocytic leukemia (APL). I. AS2O3 exerts dose-dependent dual effects on APL cells
-
Chen, G.Q., Shi, X.G., Tang, XV, Xiong, S.M., Zhu, J., Cai, X., Han, Z.G., Ni, J.H., Shi, G.Y., Jia, P.M., Liu, M.M., He, K.L., Niu, C., Ma, J., Zhang, T.D., Paul, P., Naoe, T., Kitamura, K., Miller, W., Waxman, S., Wang, Z.Y., de-The, H., Chen, S.J. & Chen, Z. (1997) Use of arsenic trioxide (AS203) in the treatment of acute promyelocytic leukemia (APL). I. AS2O3 exerts dose-dependent dual effects on APL cells. Blood, 89, 3345-3353.
-
(1997)
Blood
, vol.89
, pp. 3345-3353
-
-
Chen, G.Q.1
Shi, X.G.2
Tang, X.V.3
Xiong, S.M.4
Zhu, J.5
Cai, X.6
Han, Z.G.7
Ni, J.H.8
Shi, G.Y.9
Jia, P.M.10
Liu, M.M.11
He, K.L.12
Niu, C.13
Ma, J.14
Zhang, T.D.15
Paul, P.16
Naoe, T.17
Kitamura, K.18
Miller, W.19
Waxman, S.20
Wang, Z.Y.21
De-The, H.22
Chen, S.J.23
Chen, Z.24
more..
-
20
-
-
0026050884
-
Successful treatment of acute myeloid leukemia beyond first remission with autologous bone marrow transplantation using busulfan/cyclophosphamide and unpurged marrow: The British autograft group experience
-
Chopra, R., Goldstone, A.H. & MacMillan, A.K. (1991) Successful treatment of acute myeloid leukemia beyond first remission with autologous bone marrow transplantation using busulfan/cyclophosphamide and unpurged marrow: the British autograft group experience. Journal of Clinical Oncology. 9, 1840-1847.
-
(1991)
Journal of Clinical Oncology
, vol.9
, pp. 1840-1847
-
-
Chopra, R.1
Goldstone, A.H.2
Macmillan, A.K.3
-
21
-
-
2942712161
-
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation
-
Collins, R.H., Shpilberg, O., Drobyski, W.R., Porter, D.L., Giralt, S., Champlin, R., Goodman, S.A., Wolff, S.N., Hu, W., Verfaillie, C., List, A., Dalton, W., Ognoskie, N., Chetrit, A., Antin, J.H. & Nemunaitis, J. (1997) Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. Journal of Clinical Oncology. 15, 433-444.
-
(1997)
Journal of Clinical Oncology
, vol.15
, pp. 433-444
-
-
Collins, R.H.1
Shpilberg, O.2
Drobyski, W.R.3
Porter, D.L.4
Giralt, S.5
Champlin, R.6
Goodman, S.A.7
Wolff, S.N.8
Hu, W.9
Verfaillie, C.10
List, A.11
Dalton, W.12
Ognoskie, N.13
Chetrit, A.14
Antin, J.H.15
Nemunaitis, J.16
-
22
-
-
0030041952
-
The novel immunomodulator, Linomide, stimulates interleukin-2-induced natural killer (NK) cell and PHA-stimulated T cell proliferation from normal donors
-
Condiotti, R., Slavin, S., Barak, V. & Nagler, A. (1996) The novel immunomodulator, Linomide, stimulates interleukin-2-induced natural killer (NK) cell and PHA-stimulated T cell proliferation from normal donors. Leukemia Research, 20, 57-63.
-
(1996)
Leukemia Research
, vol.20
, pp. 57-63
-
-
Condiotti, R.1
Slavin, S.2
Barak, V.3
Nagler, A.4
-
23
-
-
0025292912
-
Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78
-
Creutzig, U., Ritter, J. & Schellong, G. (1990) Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. Blood, 75, 1452-1940.
-
(1990)
Blood
, vol.75
, pp. 1452-1940
-
-
Creutzig, U.1
Ritter, J.2
Schellong, G.3
-
24
-
-
4243890085
-
A phase 1 trial of liposomul daunorubicin (daunoxome) administered with high dose cytarabine (HiDAC) to patients with relapsed acute, leukemia
-
Cripe, L., Kneebone, P., Roberts, L., Mukwaya, G., Rutledge, C. & Gordon, M. (1998) A phase 1 trial of liposomul daunorubicin (daunoxome) administered with high dose cytarabine (HiDAC) to patients with relapsed acute, leukemia, Blood, 90. (Suppl. 1). 233a.
-
(1998)
Blood
, vol.90
, Issue.SUPPL. 1
-
-
Cripe, L.1
Kneebone, P.2
Roberts, L.3
Mukwaya, G.4
Rutledge, C.5
Gordon, M.6
-
25
-
-
0026541166
-
Second transplants for patients with chronic myeloid leukaemia in relapse after original transplant with T-depleted donor marrow: Feasibility of using busulphan alone for re-conditioning
-
Cullis, J.O., Schwarer, A.P., Hughes, T.P., Hows, J.M., Franklin, I., Morgenstern, G. & Goldman, J.M. (1992) Second transplants for patients with chronic myeloid leukaemia in relapse after original transplant with T-depleted donor marrow: feasibility of using busulphan alone for re-conditioning. British Journal of Haematology. 80, 33-39.
-
(1992)
British Journal of Haematology
, vol.80
, pp. 33-39
-
-
Cullis, J.O.1
Schwarer, A.P.2
Hughes, T.P.3
Hows, J.M.4
Franklin, I.5
Morgenstern, G.6
Goldman, J.M.7
-
26
-
-
85069113070
-
A stratification system for evaluating therapies in patients with relapsed or primary refractory myeloid leukemia
-
Estey, E., Kornblau, S. & Pierce, S. (1996) A stratification system for evaluating therapies in patients with relapsed or primary refractory myeloid leukemia. Blood. 88, 756.
-
(1996)
Blood
, vol.88
, pp. 756
-
-
Estey, E.1
Kornblau, S.2
Pierce, S.3
-
27
-
-
0028344644
-
Use of granulocyte colony stimulating factor before, during and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: Comparison with fludarabine plus cytarabine without grarmlocyte colony stimulating factor
-
Estey, E., Thall, P., Andreeff, M., Beran, M., Kantarjian, H., O'Brien, S., Escudier, S., Robertson, L.E., Koller, C., Kornblau, S., Pierce, S., Freireich, E.J., Deisseroth, A. & Keating, M. (1994) Use of granulocyte colony stimulating factor before, during and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without grarmlocyte colony stimulating factor. Journal of Clinical Oncology, 12, 672-678.
-
(1994)
Journal of Clinical Oncology
, vol.12
, pp. 672-678
-
-
Estey, E.1
Thall, P.2
Andreeff, M.3
Beran, M.4
Kantarjian, H.5
O'Brien, S.6
Escudier, S.7
Robertson, L.E.8
Koller, C.9
Kornblau, S.10
Pierce, S.11
Freireich, E.J.12
Deisseroth, A.13
Keating, M.14
-
28
-
-
4243893366
-
Randomised phase II trial of fludarabine + Ara-C + idarubicin ± all-trans retinoic acid (ATRA) ± G-CSF in poor prognosis newly-diagnosed AWT. and MDS
-
Estey, E., Thall, P., Pierce, S. & Freireich, E. (1998) Randomised phase II trial of fludarabine + Ara-C + idarubicin ± all-trans retinoic acid (ATRA) ± G-CSF in poor prognosis newly-diagnosed AWT. and MDS. Blood, 92, (Suppl. 1), 233a.
-
(1998)
Blood
, vol.92
, Issue.SUPPL. 1
-
-
Estey, E.1
Thall, P.2
Pierce, S.3
Freireich, E.4
-
29
-
-
0030861429
-
Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia
-
Falkenberg, J.H., Swit, W.M. & Williemze, R. (1997) Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia. Immunological Reviews, 157, 223-230.
-
(1997)
Immunological Reviews
, vol.157
, pp. 223-230
-
-
Falkenberg, J.H.1
Swit, W.M.2
Williemze, R.3
-
30
-
-
0031416082
-
Interleukin 2 therapy after bone marrow or stem cell transplantation for hematologic malignancies
-
Fefer, A., Robinson, N., Benyunes, M.C., Bensinger, W.I., Press, O., Thompson, J.A. & Lindgren, C. (1998) Interleukin 2 therapy after bone marrow or stem cell transplantation for hematologic malignancies. Cancer Journal Science America. 3. (Suppl, 1), S48-S53.
-
(1998)
Cancer Journal Science America
, vol.3
, Issue.SUPPL. 1
-
-
Fefer, A.1
Robinson, N.2
Benyunes, M.C.3
Bensinger, W.I.4
Press, O.5
Thompson, J.A.6
Lindgren, C.7
-
31
-
-
0031812317
-
IDA-FLAG (idarubicin, fludarabine, cytarabine, G-CSF), on effective remission-induction therapy for poor-prognosis AML of childhood prior to allogeneic or autologous bone marrow transplantation: Experiences of a phase II trial
-
Fleischhack, G., Hasan, C., Graf, N., Mann, G. & Bode, U. (1998) IDA-FLAG (idarubicin, fludarabine, cytarabine, G-CSF), on effective remission-induction therapy for poor-prognosis AML of childhood prior to allogeneic or autologous bone marrow transplantation: experiences of a phase II trial. British Journal of Haematology, 102, 647-655.
-
(1998)
British Journal of Haematology
, vol.102
, pp. 647-655
-
-
Fleischhack, G.1
Hasan, C.2
Graf, N.3
Mann, G.4
Bode, U.5
-
32
-
-
0025908320
-
Treatment of acute myeloid leukaemia patients with recombinant interleukin 2: A pilot study
-
Foa, R., Meloni, G., Tosti, S., Novarino, A., Fenu, S., Gavisto, F. & Mandelli, F. (1991) Treatment of acute myeloid leukaemia patients with recombinant interleukin 2: a pilot study. British Journal of Haematology, 77, 491-496.
-
(1991)
British Journal of Haematology
, vol.77
, pp. 491-496
-
-
Foa, R.1
Meloni, G.2
Tosti, S.3
Novarino, A.4
Fenu, S.5
Gavisto, F.6
Mandelli, F.7
-
33
-
-
0026635197
-
Cytogenetics for the detection of minimal residual disease in acute myeloid leukemia
-
Freireich, E.J., Cork, A., Stass, S.A., McCredie, K.B., Keating, M.J., Estey, E.H., Kantarjian, H.M. & Trujillo, J.M. (1992) Cytogenetics for the detection of minimal residual disease in acute myeloid leukemia. Leukemia, 6, 500-506.
-
(1992)
Leukemia
, vol.6
, pp. 500-506
-
-
Freireich, E.J.1
Cork, A.2
Stass, S.A.3
McCredie, K.B.4
Keating, M.J.5
Estey, E.H.6
Kantarjian, H.M.7
Trujillo, J.M.8
-
34
-
-
0025150433
-
Bone marrow transplantation using unrelated donors for patients with advanced leukemia or bone marrow failure
-
Gajewski, J.L., Ho, W.G. & Feig, S.A. (1990) Bone marrow transplantation using unrelated donors for patients with advanced leukemia or bone marrow failure. Transplantation, 50, 244-249.
-
(1990)
Transplantation
, vol.50
, pp. 244-249
-
-
Gajewski, J.L.1
Ho, W.G.2
Feig, S.A.3
-
35
-
-
9044235781
-
Chemotherapy versus transplants for acute myelogenous leukemia in second remission
-
Gale, R.P., Horowitz, M.M., Rees, J.K., Gray, R.G., Oken, M.M., Esley, E.H., Kim, K.M., Zhang, M.-J., Ash, R.C., Atkinson, K., Champlin, R.E., Dicke, K.A., Gajewski, J.L., Goldman, J.M., Helbig, W., Henslee-Downey, P.J., Hinterberger, W., Jacobsen, N., Keating, A., Klein. J.P., Marmont, A.M., Prentice, R.G., Reiffers. J., Rimm, A.A., Rowlings, P.A., Sobocinski, K.A., Speck, B., Wingard, J.R. & Bortin, M.M. (1996) Chemotherapy versus transplants for acute myelogenous leukemia in second remission. Leukemia, 10, 13-19.
-
(1996)
Leukemia
, vol.10
, pp. 13-19
-
-
Gale, R.P.1
Horowitz, M.M.2
Rees, J.K.3
Gray, R.G.4
Oken, M.M.5
Esley, E.H.6
Kim, K.M.7
Zhang, M.-J.8
Ash, R.C.9
Atkinson, K.10
Champlin, R.E.11
Dicke, K.A.12
Gajewski, J.L.13
Goldman, J.M.14
Helbig, W.15
Henslee-Downey, P.J.16
Hinterberger, W.17
Jacobsen, N.18
Keating, A.19
Klein, J.P.20
Marmont, A.M.21
Prentice, R.G.22
Reiffers, J.23
Rimm, A.A.24
Rowlings, P.A.25
Sobocinski, K.A.26
Speck, B.27
Wingard, J.R.28
Bortin, M.M.29
more..
-
36
-
-
0030925301
-
Engraftment of allogeneic hemopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy
-
Giralt, S., Estey, E., Albitar, M., van Besien, K., Rondon, G., Anderlini, P., O'Brien, S., Khouri. I., Gajewski, J., Mehra, R., Claxton, D., Andersson, B., Benin, M., Przepiorka, D., Koller, C., Kornblau, S., Korbling, M., Keating, M., Kantarjian, H. & Champlin, R. (1997) Engraftment of allogeneic hemopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood, 89, 4531-4536.
-
(1997)
Blood
, vol.89
, pp. 4531-4536
-
-
Giralt, S.1
Estey, E.2
Albitar, M.3
Van Besien, K.4
Rondon, G.5
Anderlini, P.6
O'Brien, S.7
Khouri, I.8
Gajewski, J.9
Mehra, R.10
Claxton, D.11
Andersson, B.12
Benin, M.13
Przepiorka, D.14
Koller, C.15
Kornblau, S.16
Korbling, M.17
Keating, M.18
Kantarjian, H.19
Champlin, R.20
more..
-
37
-
-
0025734611
-
Minimal residual disease in acute leukaemia: Preclinical studies in a relevant rat model (BNML)
-
(ed. by C. Jasmin and S. J. Proctor). Balliere Tindall, London
-
Hagenbeck, A. & Martens. A.C.M. (1991) Minimal residual disease in acute leukaemia: preclinical studies in a relevant rat model (BNML). Balliere's Clinical Haematology (ed. by C. Jasmin and S. J. Proctor). p. 609. Balliere Tindall, London.
-
(1991)
Balliere's Clinical Haematology
, pp. 609
-
-
Hagenbeck, A.1
Martens, A.C.M.2
-
38
-
-
0030895252
-
Randomised comparison of DAT versus ADE as induction chemotherapy in children and younger adults. Results of the Medical Research Council's 10th AMT, trial (AML 10)
-
Hann, L.M., Stevens, R.F., Goldstone, A.H., Wheatley, K. & Burnett, A. (1998) Randomised comparison of DAT versus ADE as induction chemotherapy in children and younger adults. Results of the Medical Research Council's 10th AMT, trial (AML 10). Blood, 89, 2311-2318.
-
(1998)
Blood
, vol.89
, pp. 2311-2318
-
-
Hann, L.M.1
Stevens, R.F.2
Goldstone, A.H.3
Wheatley, K.4
Burnett, A.5
-
39
-
-
0025732435
-
Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients of acute myeloid leukemia: A Danish National Phase III trial
-
For the Danish Society of Hematology Study Group on AML
-
Hansen, O.P., Pedersen-Bjergaard, J., Ellegaard, G., Brincker, H., Doesen, A.M., Christen, B.E., Drivsholm, A., Hippe, E., Jans, H., Jensen, K.B., Killmann, S.D., Jensen, M.K., Karle, H., Laursen, B., Nielsen, J.B. & Nissen, N.I. (1991) Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients of acute myeloid leukemia: a Danish National Phase III trial. For the Danish Society of Hematology Study Group on AML. Leukemia. 5, 510-516.
-
(1991)
Leukemia
, vol.5
, pp. 510-516
-
-
Hansen, O.P.1
Pedersen-Bjergaard, J.2
Ellegaard, G.3
Brincker, H.4
Doesen, A.M.5
Christen, B.E.6
Drivsholm, A.7
Hippe, E.8
Jans, H.9
Jensen, K.B.10
Killmann, S.D.11
Jensen, M.K.12
Karle, H.13
Laursen, B.14
Nielsen, J.B.15
Nissen, N.I.16
-
40
-
-
0041442548
-
Results of a randomised double Wind placebo controlled phase III study of filgrastim in remission induction and early consolidation therapy for adults with de novo acute mycloid leukemia
-
Heil, G., Hoelzer, D., Sanz, M.A., Lechner, K., Liu Yin, J., Papa, G., Noens, L., Ho, J., O'Brien, C., Matcham, J. & Barge, A. (1995) Results of a randomised double Wind placebo controlled phase III study of filgrastim in remission induction and early consolidation therapy for adults with de novo acute mycloid leukemia. Blood, 86, (Suppl. 1), 267a.
-
(1995)
Blood
, vol.86
, Issue.SUPPL. 1
-
-
Heil, G.1
Hoelzer, D.2
Sanz, M.A.3
Lechner, K.4
Liu Yin, J.5
Papa, G.6
Noens, L.7
Ho, J.8
O'brien, C.9
Matcham, J.10
Barge, A.11
-
41
-
-
0020546405
-
High-dose cytosine arabinoside therapy for refractory leukemia
-
Hertzig, R.H., Wolff, S.N., Lazarus, H.M., Phillips, G.L., Karanes, C. & Herzig, G.P. (1983) High-dose cytosine arabinoside therapy for refractory leukemia, Blood, 62, 161-369.
-
(1983)
Blood
, vol.62
, pp. 161-369
-
-
Hertzig, R.H.1
Wolff, S.N.2
Lazarus, H.M.3
Phillips, G.L.4
Karanes, C.5
Herzig, G.P.6
-
42
-
-
0025329042
-
Durable complete remission of acute nonlymphocytic leukemia associated with discontinuation of immunosuppression following relapse after allogeneic bone marrow transplantation: A case report of a probable graft-versus-leukemia effect
-
Higano, C.S., Brixey, M., Bryant, E.M., Durnam, D.M., Doney. K., Sullivan, K.M. & Singer. J.W. (1990) Durable complete remission of acute nonlymphocytic leukemia associated with discontinuation of immunosuppression following relapse after allogeneic bone marrow transplantation: a case report of a probable graft-versus-leukemia effect. Transplantation. 50, 175-177.
-
(1990)
Transplantation
, vol.50
, pp. 175-177
-
-
Higano, C.S.1
Brixey, M.2
Bryant, E.M.3
Durnam, D.M.4
Doney, K.5
Sullivan, K.M.6
Singer, J.W.7
-
43
-
-
0025100777
-
Graft-versus-leukemia reactions after bone marrow transplantation
-
Horowitz, M.M., Gale, R.P. & Sondel, P.M. (1990) Graft-versus-leukemia reactions after bone marrow transplantation. Blood, 75, 555-562.
-
(1990)
Blood
, vol.75
, pp. 555-562
-
-
Horowitz, M.M.1
Gale, R.P.2
Sondel, P.M.3
-
44
-
-
12644313240
-
FLAG (fludarabine, cytosine, arabinoside, G-CSFJ for refractory and relapsed acute leukemia
-
Huhmann, I.M., Watzke, H.H. & Geissler, K. (1996) FLAG (fludarabine, cytosine, arabinoside, G-CSFJ for refractory and relapsed acute leukemia. Annals of Hematology, 73, 256-271.
-
(1996)
Annals of Hematology
, vol.73
, pp. 256-271
-
-
Huhmann, I.M.1
Watzke, H.H.2
Geissler, K.3
-
45
-
-
0001279030
-
Potential for myeloablation with ytrium-90-labelled HuM195 (anti-CD33): A phase I trial in advanced myeloid leukemias
-
Jurcic, J.G., Divgi, C.R., McDevitt, M.R., Ma, D., Sgouros, G., Finn, R.D., Larson, S.M. & Scheinberg, D.A. (1998) Potential for myeloablation with ytrium-90-labelled HuM195 (anti-CD33): a phase I trial in advanced myeloid leukemias. Blood, 92, (Suppl. 1), 613a.
-
(1998)
Blood
, vol.92
, Issue.SUPPL. 1
-
-
Jurcic, J.G.1
Divgi, C.R.2
McDevitt, M.R.3
Ma, D.4
Sgouros, G.5
Finn, R.D.6
Larson, S.M.7
Scheinberg, D.A.8
-
46
-
-
9544257262
-
Persistence of the AML1/ETO fusion transcipt in patients treated with allogeneic bone marrow transplantation for t(8:21) leukemia
-
Jurlander, J., Caligiuri, M.A., Ruotu, T., Baer, M.R., Strout, M.P., Oberkircher, A.R., Hoffmann, L., Ball, E.D., Frei-Lahr, D.A., Christiansen, N.P., Block, A.M., Knuutila, S., Herzig, G.P. & Bloomfield, C.D. (1996) Persistence of the AML1/ETO fusion transcipt in patients treated with allogeneic bone marrow transplantation for t(8:21) leukemia. Blood. 88, 2183-2191.
-
(1996)
Blood
, vol.88
, pp. 2183-2191
-
-
Jurlander, J.1
Caligiuri, M.A.2
Ruotu, T.3
Baer, M.R.4
Strout, M.P.5
Oberkircher, A.R.6
Hoffmann, L.7
Ball, E.D.8
Frei-Lahr, D.A.9
Christiansen, N.P.10
Block, A.M.11
Knuutila, S.12
Herzig, G.P.13
Bloomfield, C.D.14
-
47
-
-
0024379549
-
Response to salvage therapy and survival after relapse in acute myelogenous leukemia
-
Keating, M.J., Kantarjian, H. & Smith, T.L. (1989) Response to salvage therapy and survival after relapse in acute myelogenous leukemia. Journal of Clinical Oncology. 7, 1071-1080.
-
(1989)
Journal of Clinical Oncology
, vol.7
, pp. 1071-1080
-
-
Keating, M.J.1
Kantarjian, H.2
Smith, T.L.3
-
48
-
-
0023711896
-
Cytogenetic pattern in acute myelogenous leukemia: A major reproducible determinant of outcome
-
Keating, M.J., Smith, T.L., Kantarjian, H., Cork, A., Walters, R., Trujillo, J.M., McCredie, K.B., Gehan, E.A. & Freireich, E.J. (1988) Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome, Leukemia. 2, 403-412.
-
(1988)
Leukemia
, vol.2
, pp. 403-412
-
-
Keating, M.J.1
Smith, T.L.2
Kantarjian, H.3
Cork, A.4
Walters, R.5
Trujillo, J.M.6
McCredie, K.B.7
Gehan, E.A.8
Freireich, E.J.9
-
49
-
-
8944240836
-
Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission; An analysis of the EORTC-GIMEMA AML 8A trial
-
The EORTC and GIMEMA Leukemia Cooperative Groups
-
Keating, S., Suciu, S. de Witte, T., Mandelli, F., Willemze, R., Resegotti, L., Broccia, G., Thaler, J., Labar, B., Damasio, E., Bizzi, B., Rotoli, B., Vekhoff, A., Muus, P., Petti, M.C., Dardenne, M., Solbu, G., Vegna, M.L., & Zittoun, R.A. (1996) Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission; an analysis of the EORTC-GIMEMA AML 8A trial. The EORTC and GIMEMA Leukemia Cooperative Groups. Bone Marrow Transplantation. 17, 993-1001.
-
(1996)
Bone Marrow Transplantation
, vol.17
, pp. 993-1001
-
-
Keating, S.1
Suciu, S.2
De Witte, T.3
Mandelli, F.4
Willemze, R.5
Resegotti, L.6
Broccia, G.7
Thaler, J.8
Labar, B.9
Damasio, E.10
Bizzi, B.11
Rotoli, B.12
Vekhoff, A.13
Muus, P.14
Petti, M.C.15
Dardenne, M.16
Solbu, G.17
Vegna, M.L.18
Zittoun, R.A.19
-
50
-
-
0030916862
-
Donor leukocyte infusions for leukemic relapse after allogeneic marrow transplantation: Lack of residual donor hematopoiesis predicts aplasia
-
Keil, E., Haas, O.A., Fritsch, G., Kahls, P., Lechner, K., Mannhalter, C., Reiter, E., Niederweiser, D., Hoecker, P. & Greinix, H.T. (1997) Donor leukocyte infusions for leukemic relapse after allogeneic marrow transplantation: lack of residual donor hematopoiesis predicts aplasia. Blood, 89, 3113-3117.
-
(1997)
Blood
, vol.89
, pp. 3113-3117
-
-
Keil, E.1
Haas, O.A.2
Fritsch, G.3
Kahls, P.4
Lechner, K.5
Mannhalter, C.6
Reiter, E.7
Niederweiser, D.8
Hoecker, P.9
Greinix, H.T.10
-
51
-
-
17344366634
-
Superiority of high-dose over intermediate dose cytosine arabinoside in the treatment of patients with high risk acute myeloid leukemia: Results of an age-adjusted prospective randomised comparison
-
Kern, W. Aul, C., Maschmeyer, G., Schonrock-Nahulsi, R., Ludwig, W.D., Bartholomaus, A., Bettelheim, P., Wormann, B., Buchner, T. & Hiddemann, W, (1998) Superiority of high-dose over intermediate dose cytosine arabinoside in the treatment of patients with high risk acute myeloid leukemia: results of an age-adjusted prospective randomised comparison, Leukemia, 12, 1049-1055.
-
(1998)
Leukemia
, vol.12
, pp. 1049-1055
-
-
Kern, W.1
Aul, C.2
Maschmeyer, G.3
Schonrock-Nahulsi, R.4
Ludwig, W.D.5
Bartholomaus, A.6
Bettelheim, P.7
Wormann, B.8
Buchner, T.9
Hiddemann, W.10
-
52
-
-
85069108795
-
Different effects of all-trans retinoic acid and etoposide on down-regulation of bcl-2 in apoptosis associated with cytochrome C efflux and caspase activation in acute mycloblastic leukemia cells
-
Koistinen, P., Zheng, A., Siitonen, T., Mantymaa, P., Saily, M. & Savolainen, E.-R. (1998) Different effects of all-trans retinoic acid and etoposide on down-regulation of bcl-2 in apoptosis associated with cytochrome C efflux and caspase activation in acute mycloblastic leukemia cells. Blood, 92, (Suppl. 1), 600a.
-
(1998)
Blood
, vol.92
, Issue.SUPPL. 1
-
-
Koistinen, P.1
Zheng, A.2
Siitonen, T.3
Mantymaa, P.4
Saily, M.5
Savolainen, E.-R.6
-
53
-
-
0027220994
-
Adoptive immunotherapy in human find canine chimeras: The role of Interferon α
-
Kolb, H.J., Mittermuller, J., Hertenstein. H., Schumm, M., Holler, E., de Witte, T., Gunther, W. & Goldman. J. (1993) Adoptive immunotherapy in human find canine chimeras: the role of Interferon α. Seminars in Hematology, 30, 37-39.
-
(1993)
Seminars in Hematology
, vol.30
, pp. 37-39
-
-
Kolb, H.J.1
Mittermuller, J.2
Hertenstein, H.3
Schumm, M.4
Holler, E.5
De Witte, T.6
Gunther, W.7
Goldman, J.8
-
54
-
-
0029744389
-
Clinical and laboratory studies of 2-chlorodeoxyadenosine ± cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adults
-
Kornblau, S.M., Gandhi, V., Andreef, H.M., Beran, M., Kantarjian, H.M., Koller, C.A., O'Brien, S., Plunkett, W. & Estey, E. (1996) Clinical and laboratory studies of 2-chlorodeoxyadenosine ± cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adults. Leukemia, 10, 1563-1569.
-
(1996)
Leukemia
, vol.10
, pp. 1563-1569
-
-
Kornblau, S.M.1
Gandhi, V.2
Andreef, H.M.3
Beran, M.4
Kantarjian, H.M.5
Koller, C.A.6
O'Brien, S.7
Plunkett, W.8
Estey, E.9
-
55
-
-
0028347630
-
Late effects of intensive treatment for acute myeloid leukaemia and myelodysplasia in childhood
-
Liesner, R.J., Leiper, A.D., Hann, L.M. & Chessels, J.M. (1994) Late effects of intensive treatment for acute myeloid leukaemia and myelodysplasia in childhood. Journal of Clinical Oncology. 12, 916-924.
-
(1994)
Journal of Clinical Oncology
, vol.12
, pp. 916-924
-
-
Liesner, R.J.1
Leiper, A.D.2
Hann, L.M.3
Chessels, J.M.4
-
56
-
-
0026031848
-
Late effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood
-
Lipshultz, S.E., Colan, S.D., Gelber, R.D., Perez-Atadye, A.R., Sallan, S.E. & Sanders, S.P. (1991) Late effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. New England Journal of Medicine. 324, 808-814.
-
(1991)
New England Journal of Medicine
, vol.324
, pp. 808-814
-
-
Lipshultz, S.E.1
Colan, S.D.2
Gelber, R.D.3
Perez-Atadye, A.R.4
Sallan, S.E.5
Sanders, S.P.6
-
57
-
-
0030058445
-
Role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia
-
List, A.F. (1996) Role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia. Leukemia. 10, 937-942.
-
(1996)
Leukemia
, vol.10
, pp. 937-942
-
-
List, A.F.1
-
58
-
-
0000038344
-
Benefit of cyclosporine (CsA) modulation of anthracycline resistance in high-risk AML: A Southwest Oncology Group study
-
List, A.F., Kopecky, K.J., Willman, C.L., Spier, C., Dorr, R., Flaherty, L., Hynes, H. & Appelbaum, F. (1998) Benefit of cyclosporine (CsA) modulation of anthracycline resistance in high-risk AML: a Southwest Oncology Group study. Blood. 92, (Suppl. 1). 312a.
-
(1998)
Blood
, vol.92
, Issue.SUPPL. 1
-
-
List, A.F.1
Kopecky, K.J.2
Willman, C.L.3
Spier, C.4
Dorr, R.5
Flaherty, L.6
Hynes, H.7
Appelbaum, F.8
-
59
-
-
0030825408
-
Molecular remission in PML/RARα positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy
-
Mandelli, F., Diverio, D., Avvisati, G., Luciano, A., Barbui, T., Bernasconi, C, Broccia, G., Cerri, R., Falda, M., Fioritoni, G., Leoni, E., Liso, V., Petti, M.C., Rodeghiero, E., Saglio, G., Vegna, M.L., Visano, G., Jehn, H., Willemze, R., Muus, P., Pelicci, P.G., Biondi, A. & LaCocco, F. (1997) Molecular remission in PML/RARα positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Blood, 90, 1014-1019.
-
(1997)
Blood
, vol.90
, pp. 1014-1019
-
-
Mandelli, F.1
Diverio, D.2
Avvisati, G.3
Luciano, A.4
Barbui, T.5
Bernasconi, C.6
Broccia, G.7
Cerri, R.8
Falda, M.9
Fioritoni, G.10
Leoni, E.11
Liso, V.12
Petti, M.C.13
Rodeghiero, E.14
Saglio, G.15
Vegna, M.L.16
Visano, G.17
Jehn, H.18
Willemze, R.19
Muus, P.20
Pelicci, P.G.21
Biondi, A.22
Lacocco, F.23
more..
-
60
-
-
0025884494
-
A randomised clinical trial comparing idarubicin und cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukemia. A multicentric study from the Italian Co-operative Group GIMEMA
-
Mandelli, E., Petti, M.C., Ardia, A., Di Pietro, N., Di Raimondo, E., Ganzina, F., Falconi, E., Geraci, E., Ladogana, S., Latagliata, R., Malleo, C., Nobile, E., Petti, N., Rotoli, B., Specchia, G., Tabilio, A. & Luigi, R. (1991) A randomised clinical trial comparing idarubicin und cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukemia. A multicentric study from the Italian Co-operative Group GIMEMA. European Journal of Cancer, 27, 750-755.
-
(1991)
European Journal of Cancer
, vol.27
, pp. 750-755
-
-
Mandelli, E.1
Petti, M.C.2
Ardia, A.3
Di Pietro, N.4
Di Raimondo, E.5
Ganzina, F.6
Falconi, E.7
Geraci, E.8
Ladogana, S.9
Latagliata, R.10
Malleo, C.11
Nobile, E.12
Petti, N.13
Rotoli, B.14
Specchia, G.15
Tabilio, A.16
Luigi, R.17
-
61
-
-
0028918255
-
Clinical and prognostic significance of chromosomal abnormalities in childhood acute mycloid leukemia de novo
-
Martinez-Climent, J.A., Lane, N.J., Rubin, C.M., Morgan, E., Johnstone, H.S., Mick, R., Murphy, S.B., Vardiman, J.W., Larson, R.A. & Le Beau, M.M. (1995) Clinical and prognostic significance of chromosomal abnormalities in childhood acute mycloid leukemia de novo. Leukemia, 9, 95-101.
-
(1995)
Leukemia
, vol.9
, pp. 95-101
-
-
Martinez-Climent, J.A.1
Lane, N.J.2
Rubin, C.M.3
Morgan, E.4
Johnstone, H.S.5
Mick, R.6
Murphy, S.B.7
Vardiman, J.W.8
Larson, R.A.9
Le Beau, M.M.10
-
62
-
-
0027941369
-
Intensive postremission chemotherapy in adults with acute mycloid leukemia
-
Mayer, R.J., David, R.B., Schiffer, C.A., Berg, D.T., Powell, B.L., Schulman, P., Omura, G.A., Moore, J.O., McIntyre, O.R. & Frei, E. (1994) Intensive postremission chemotherapy in adults with acute mycloid leukemia. New England Journal of Medicine, 331, 896-903.
-
(1994)
New England Journal of Medicine
, vol.331
, pp. 896-903
-
-
Mayer, R.J.1
David, R.B.2
Schiffer, C.A.3
Berg, D.T.4
Powell, B.L.5
Schulman, P.6
Omura, G.A.7
Moore, J.O.8
McIntyre, O.R.9
Frei, E.10
-
63
-
-
0030996274
-
Outcome of acute leukaemia relapsing after bone marrow transplantation: Utility of second transplants and adoptive immunotherapy
-
Mehta, J., Powles, R., Treleaven, J., Horton, C., Meller, S., Pinkerton, C.R. Singhal, S. (1997) Outcome of acute leukaemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapy. Bone Marrow Transplantation, 19, 709-719.
-
(1997)
Bone Marrow Transplantation
, vol.19
, pp. 709-719
-
-
Mehta, J.1
Powles, R.2
Treleaven, J.3
Horton, C.4
Meller, S.5
Pinkerton, C.R.6
Singhal, S.7
-
64
-
-
0028145247
-
Interleukin 2 may induce prolonged remissions in advanced acute myelogenous leukemia
-
Meloni, G., Foa, R., Vignetti, M., Guarini, A., Fenu, S., Tosti, S., Tos, A.G. & Mandelli, F. (1994) Interleukin 2 may induce prolonged remissions in advanced acute myelogenous leukemia. Blood, 84, 2158-2163.
-
(1994)
Blood
, vol.84
, pp. 2158-2163
-
-
Meloni, G.1
Foa, R.2
Vignetti, M.3
Guarini, A.4
Fenu, S.5
Tosti, S.6
Tos, A.G.7
Mandelli, F.8
-
65
-
-
0029866914
-
Interleukin 2 for the treatment of advanced acute myelogenous leukemia patients with limited disease: Updated experience with 20 cases
-
Meloni, G., Vignetti, M., Andrizzi, C., Capria, S., Foa, R. & Mandelli, F. (1996) Interleukin 2 for the treatment of advanced acute myelogenous leukemia patients with limited disease: updated experience with 20 cases. Leukemia and Lymphoma, 21, 429-435.
-
(1996)
Leukemia and Lymphoma
, vol.21
, pp. 429-435
-
-
Meloni, G.1
Vignetti, M.2
Andrizzi, C.3
Capria, S.4
Foa, R.5
Mandelli, F.6
-
66
-
-
0027650626
-
Long-term follow up of three cases of acute myeloid leukaemia with inv(16) (p13q22)
-
Miura, I., Cyubachi, A., Hashimoto, K., Nishinari, T., Nimura, T. & Miura, A.B. (1993) Long-term follow up of three cases of acute myeloid leukaemia with inv(16) (p13q22). Rinso-Ketsueki, 34, 942-945.
-
(1993)
Rinso-Ketsueki
, vol.34
, pp. 942-945
-
-
Miura, I.1
Cyubachi, A.2
Hashimoto, K.3
Nishinari, T.4
Nimura, T.5
Miura, A.B.6
-
67
-
-
0028950916
-
Improved survival for patients with acute myeloid leukemia
-
Mitus, A.J., Miller, K.B., Schenkein, D.P., Ryan, H.F., Parsons, S.K., Wheeler, C. & Antin, J.H. (1995) Improved survival for patients with acute myeloid leukemia. Journal of Clinical Oncology. 13, 560-569.
-
(1995)
Journal of Clinical Oncology
, vol.13
, pp. 560-569
-
-
Mitus, A.J.1
Miller, K.B.2
Schenkein, D.P.3
Ryan, H.F.4
Parsons, S.K.5
Wheeler, C.6
Antin, J.H.7
-
68
-
-
0026524521
-
Second BLA identical transplants for leukemia recurrence
-
Mrsic, M., Horowitz, M.M., Atkinson, K., Biggs, J.C., Champlin, R.E., Ehninger, G., Gajewski, J.L., Gale, R.P., Herzig, R.H., Prentice, H.G., Roxman, C., Sobocinski, K.A., Speck, B. & Bortin, M.M. (1992) Second BLA identical transplants for leukemia recurrence. Bone Marrow Transplantation, 9, 269-275.
-
(1992)
Bone Marrow Transplantation
, vol.9
, pp. 269-275
-
-
Mrsic, M.1
Horowitz, M.M.2
Atkinson, K.3
Biggs, J.C.4
Champlin, R.E.5
Ehninger, G.6
Gajewski, J.L.7
Gale, R.P.8
Herzig, R.H.9
Prentice, H.G.10
Roxman, C.11
Sobocinski, K.A.12
Speck, B.13
Bortin, M.M.14
-
69
-
-
0027317604
-
Persistence of the 8:21 translocation in patients with acute myeloid leukemia type M2 in long-term remission
-
Nucifora, G., Larson, R.A. & Rowley, J.D. (1991) Persistence of the 8:21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood, 82, 712-715.
-
(1991)
Blood
, vol.82
, pp. 712-715
-
-
Nucifora, G.1
Larson, R.A.2
Rowley, J.D.3
-
70
-
-
0025187881
-
Effect of granulocyte-colony stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia
-
Ohno, R., Tomonaga, M., Kobayashi, T., Kanamaru, A., Shrakawa, S., Masaoka, T., Omine, M., Oh, H., Nomura, T., Sakai, Y., Hirano, M., Yokomaku, S., Nakayma, S., Yoshida, Y., Miura, A.D., Morishima, Y., Dohy, H., Niho, Y., Hamajima, N. & Tak, F. (1990) Effect of granulocyte-colony stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia. New England journal of Medicine, 323, 871-874.
-
(1990)
New England Journal of Medicine
, vol.323
, pp. 871-874
-
-
Ohno, R.1
Tomonaga, M.2
Kobayashi, T.3
Kanamaru, A.4
Shrakawa, S.5
Masaoka, T.6
Omine, M.7
Oh, H.8
Nomura, T.9
Sakai, Y.10
Hirano, M.11
Yokomaku, S.12
Nakayma, S.13
Yoshida, Y.14
Miura, A.D.15
Morishima, Y.16
Dohy, H.17
Niho, Y.18
Hamajima, N.19
Tak, F.20
more..
-
71
-
-
0027196772
-
Multiple chromosome abnormalities in patients with acute leukemia after autologous bone marrow transplantation using total body irradiation and marrow purged with ifosfamide
-
Perot, C., van-den-Akker, J., Laporte, J.P., Douay, L., Lopez, M., Stachowiak, J., Isnard, F., Taillemite, J.L., Najman, A. & Gorin, N.C. (1993) Multiple chromosome abnormalities in patients with acute leukemia after autologous bone marrow transplantation using total body irradiation and marrow purged with ifosfamide. Leukemia, 7, 509-515.
-
(1993)
Leukemia
, vol.7
, pp. 509-515
-
-
Perot, C.1
Van-Den-Akker, J.2
Laporte, J.P.3
Douay, L.4
Lopez, M.5
Stachowiak, J.6
Isnard, F.7
Taillemite, J.L.8
Najman, A.9
Gorin, N.C.10
-
72
-
-
0027245918
-
Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission
-
Petersen, F.B., Lynch, M.H. & Clift, R.A. (1995) Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission, journal of Clinical Oncology. 11, 1353-1360.
-
(1995)
Journal of Clinical Oncology
, vol.11
, pp. 1353-1360
-
-
Petersen, F.B.1
Lynch, M.H.2
Clift, R.A.3
-
73
-
-
0026093499
-
Determinants of response and prediction of response to chemotherapy in acute myelogenous leukaemia
-
Preisler, H.D. (1991) Determinants of response and prediction of response to chemotherapy in acute myelogenous leukaemia. Balliere's Clinical Haematology. 69-93.
-
(1991)
Balliere's Clinical Haematology
, pp. 69-93
-
-
Preisler, H.D.1
-
75
-
-
0027409544
-
Second allogeneic marrow transplantation For patients with recurrent leukemia after initial transplant with total-body irradiation containing regimens
-
Radich, J.P., Sanders, J.E., Buckner, C.D., Martin, P.J., Petersen, F.B., Bensinger, W., McDonald, G.B., Mon, M., Schoch, G. & Hansen. J.A. (1993) Second allogeneic marrow transplantation For patients with recurrent leukemia after initial transplant with total-body irradiation containing regimens. Journal of Clinical Oncology. 11, 304-313.
-
(1993)
Journal of Clinical Oncology
, vol.11
, pp. 304-313
-
-
Radich, J.P.1
Sanders, J.E.2
Buckner, C.D.3
Martin, P.J.4
Petersen, F.B.5
Bensinger, W.6
McDonald, G.B.7
Mon, M.8
Schoch, G.9
Hansen, J.A.10
-
76
-
-
0027741362
-
Treatment of minimal residual disease in myeloid leukemia: The immunotherapeutic options with emphasis on linomide
-
Rowe, J.M., Nilsson. B.I. & Simonsson, B. (1993) Treatment of minimal residual disease in myeloid leukemia: the immunotherapeutic options with emphasis on linomide. Leukemia and Lymphoma, 11, 321-329.
-
(1993)
Leukemia and Lymphoma
, vol.11
, pp. 321-329
-
-
Rowe, J.M.1
Nilsson, B.I.2
Simonsson, B.3
-
77
-
-
0023841266
-
Second marrow transplants in patients with leukemia who relapse after allogeneic marrow transplantation
-
Sanders, J.E., Buckner, C.D., Clift, R.A., Fefer, A., McGuffin, R., Storb, R., Appelbaum, E., Bensinger, W., Beatty, P. & Doney, K. (1988) Second marrow transplants in patients with leukemia who relapse after allogeneic marrow transplantation. Bone Marrow Transplantation. 3, 11-19.
-
(1988)
Bone Marrow Transplantation
, vol.3
, pp. 11-19
-
-
Sanders, J.E.1
Buckner, C.D.2
Clift, R.A.3
Fefer, A.4
McGuffin, R.5
Storb, R.6
Appelbaum, E.7
Bensinger, W.8
Beatty, P.9
Doney, K.10
-
78
-
-
1842375675
-
Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients
-
San-Miguel, J.F., Martinez, A., Macedo, A., Vidiriales, M.B., Lopez-Berges, C., Gonzalez, M., Cabellero, D., Garcia-Marcos, M.A., Romos, F., Fernandez-Calvo, J., Calmuntia, M.J., Dian-Mediavilla, J. & Orfao, A. (1997) Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients. Blood, 90, 2465-2470.
-
(1997)
Blood
, vol.90
, pp. 2465-2470
-
-
San-Miguel, J.F.1
Martinez, A.2
Macedo, A.3
Vidiriales, M.B.4
Lopez-Berges, C.5
Gonzalez, M.6
Cabellero, D.7
Garcia-Marcos, M.A.8
Romos, F.9
Fernandez-Calvo, J.10
Calmuntia, M.J.11
Dian-Mediavilla, J.12
Orfao, A.13
-
79
-
-
0026536178
-
2-chlorodeoxyadenosine produces a high rate of complete remission in relapsed acute myeloid leukemia
-
Santana, V.M., Mirro, J., Kearns, C., Schell, M.J., Crom, W., & Blakley, R.L. (1992) 2-Chlorodeoxyadenosine produces a high rate of complete remission in relapsed acute myeloid leukemia. Journal of Clinical Oncology. 10, 364-570.
-
(1992)
Journal of Clinical Oncology
, vol.10
, pp. 364-570
-
-
Santana, V.M.1
Mirro, J.2
Kearns, C.3
Schell, M.J.4
Crom, W.5
Blakley, R.L.6
-
80
-
-
4243570147
-
Peripheral blood progenitor cell (PBSC) versus bone marrow (BM) transplants from HLA-identical donors - A joint analysis of the International Bone Marrow Transplant Registry (IBMTR) and the European Group for Blood and Bone Marrow Transplantation (EBMT)
-
Schmitz, N., Champlin, R. Horowitz, M. & Gratwohl, A. (1998) Peripheral blood progenitor cell (PBSC) versus bone marrow (BM) transplants from HLA-identical donors - a joint analysis of the International Bone Marrow Transplant Registry (IBMTR) and the European Group for Blood and Bone Marrow Transplantation (EBMT). Bone Marrow Transplantation. 21. (Suppl. 1), S43.
-
(1998)
Bone Marrow Transplantation
, vol.21
, Issue.SUPPL. 1
-
-
Schmitz, N.1
Champlin, R.2
Horowitz, M.3
Gratwohl, A.4
-
81
-
-
0031884911
-
Feasibility, toxicity, and biologic response of interleukin-2 after consolidation chemotherapy for acute myelogenous leukemia: A report from the Children's Cancer Group
-
Sievers, E.L., Lange, B.J., Sondel, P.M., Krailo, M.D., Gan, J., Liu-Mares, W. & Feig, S.A. (1998a) Feasibility, toxicity, and biologic response of interleukin-2 after consolidation chemotherapy for acute myelogenous leukemia: a report from the Children's Cancer Group, journal of Clinical Oncology, 16, 914-919.
-
(1998)
Journal of Clinical Oncology
, vol.16
, pp. 914-919
-
-
Sievers, E.L.1
Lange, B.J.2
Sondel, P.M.3
Krailo, M.D.4
Gan, J.5
Liu-Mares, W.6
Feig, S.A.7
-
82
-
-
0003247440
-
Interim analysis of the efficacy and safety of CMA-676 in patients with AML in first relapse
-
Sievers, E.L., Larson, R.A., Estey, E., Stadtmauer, E., Berger, M., Eten, C., Bernstein, I. & Appelbaum, F. (1998b) Interim analysis of the efficacy and safety of CMA-676 in patients with AML in first relapse. Blood. 92, (Suppl. 1), 613a.
-
(1998)
Blood
, vol.92
, Issue.SUPPL. 1
-
-
Sievers, E.L.1
Larson, R.A.2
Estey, E.3
Stadtmauer, E.4
Berger, M.5
Eten, C.6
Bernstein, I.7
Appelbaum, F.8
-
83
-
-
0032006125
-
Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases
-
Slavin, S., Nagler, A., Naparstek, E., Kapelushnik, Y., Aker, M., Cividalli, G., Varadi, G., Kirschbaum, M., Ackerstein, A., Samuel, S., Amar, A., Brautbar, C., Ben-Tal, O., Eldor, A. & Or. R. (1998) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood. 91, 756-763.
-
(1998)
Blood
, vol.91
, pp. 756-763
-
-
Slavin, S.1
Nagler, A.2
Naparstek, E.3
Kapelushnik, Y.4
Aker, M.5
Cividalli, G.6
Varadi, G.7
Kirschbaum, M.8
Ackerstein, A.9
Samuel, S.10
Amar, A.11
Brautbar, C.12
Ben-Tal, O.13
Eldor, A.14
Or, R.15
-
84
-
-
85069116558
-
Arsenic trioxide in acute promyelocytic leukemia: Results of initial US pilot and multicenter trials
-
Soignet, S., Kantarjian, H., Frankel, S., Douer, D., Tallman, M., Scheinberg, D., Pandolfi, P., Elison, R, & Warrell, R. (1998) Arsenic trioxide in acute promyelocytic leukemia: results of initial US pilot and multicenter trials. Blood, 92, (Suppl. 1), 483a.
-
(1998)
Blood
, vol.92
, Issue.SUPPL. 1
-
-
Soignet, S.1
Kantarjian, H.2
Frankel, S.3
Douer, D.4
Tallman, M.5
Scheinberg, D.6
Pandolfi, P.7
Elison, R.8
Warrell, R.9
-
85
-
-
0031682976
-
Duration of first remission predicts remission rates and longterm survival in children with relapsed acute mycloid leukemia
-
Stahuke, K., Boos, J., Bender-Gotze, C., Ritter, J., Zimmermann, M. & Creutzig, U. (1998) Duration of first remission predicts remission rates and longterm survival in children with relapsed acute mycloid leukemia. Leukemia, 12, 1534-1538.
-
(1998)
Leukemia
, vol.12
, pp. 1534-1538
-
-
Stahuke, K.1
Boos, J.2
Bender-Gotze, C.3
Ritter, J.4
Zimmermann, M.5
Creutzig, U.6
-
86
-
-
0029963320
-
Therapy of refractory or recurrent childhood acute mycloid leukemia using amsacrine and etoposide with or without axacitidine: A Pediatric Oncology Group randomised phase II study
-
Steuber, C.P., Krischer, J., Holbrook, T., Camitta, B., Land, V., Sexauer, C., Mahoney, D, & Weinstein, H. (1996) Therapy of refractory or recurrent childhood acute mycloid leukemia using amsacrine and etoposide with or without axacitidine: a Pediatric Oncology Group randomised phase II study. Journal of Clinical Oncology. 14, 1521-1525.
-
(1996)
Journal of Clinical Oncology
, vol.14
, pp. 1521-1525
-
-
Steuber, C.P.1
Krischer, J.2
Holbrook, T.3
Camitta, B.4
Land, V.5
Sexauer, C.6
Mahoney, D.7
Weinstein, H.8
-
87
-
-
0031958821
-
Marked improvements in outcome with chemotherapy alone in paediatric acute mycloid leukaemia: Results of the United Kingdom Medical Research Council's 10th AML trial
-
Stevens, R.F., Hann, I.M., Wheatley, K. & Gray. R.C. (1998) Marked improvements in outcome with chemotherapy alone in paediatric acute mycloid leukaemia: results of the United Kingdom Medical Research Council's 10th AML trial. British Journal of Haematology. 101, 130-140.
-
(1998)
British Journal of Haematology
, vol.101
, pp. 130-140
-
-
Stevens, R.F.1
Hann, I.M.2
Wheatley, K.3
Gray, R.C.4
-
88
-
-
0024566585
-
Influence of acute und chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia
-
Sullivan, K.M., Weiden, P.L. & Storb, R. (1989) Influence of acute und chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood, 73, 1720-1728.
-
(1989)
Blood
, vol.73
, pp. 1720-1728
-
-
Sullivan, K.M.1
Weiden, P.L.2
Storb, R.3
-
89
-
-
0030923479
-
All-trans retinoic acid in acute promyelocytic leukemia
-
Tallman, M.S., Andersen, J.W., Schiffer, C.A., Appelbaum, F.R. F.R., Feusner, J.H., Ogden, A., Shepherd, L., Willman, C., Bloomfield, C.D., Rowe, J.M. & Wiernik, P.H. (1997) All-trans retinoic acid in acute promyelocytic leukemia. New England Journal of Medicine, 337, 1021-1028.
-
(1997)
New England Journal of Medicine
, vol.337
, pp. 1021-1028
-
-
Tallman, M.S.1
Andersen, J.W.2
Schiffer, C.A.3
Appelbaum, F.R.4
Feusner, J.H.5
Ogden, A.6
Shepherd, L.7
Willman, C.8
Bloomfield, C.D.9
Rowe, J.M.10
Wiernik, P.H.11
-
90
-
-
15844378214
-
Duration of second complete remission in patients with acute myeloid leukemia treated with chemotherapy: A retrospective single-center study
-
Thalhammer, E., Geissler, K., Jager, U., Kyrle, H, Pabinger, L., Mitterbauer, M., Gisslinger, H., Knobl, P., Laczika, K., Schneider, B., Haas, O. & Lechner, K. (1996) Duration of second complete remission in patients with acute myeloid leukemia treated with chemotherapy: a retrospective single-center study. Annals of Haematology. 72, 216-222.
-
(1996)
Annals of Haematology
, vol.72
, pp. 216-222
-
-
Thalhammer, E.1
Geissler, K.2
Jager, U.3
Kyrle, H.4
Pabinger, L.5
Mitterbauer, M.6
Gisslinger, H.7
Knobl, P.8
Laczika, K.9
Schneider, B.10
Haas, O.11
Lechner, K.12
-
91
-
-
0005040904
-
A systematic collaborative overview of randomized trials comparing idarubicin with daunorubicin for other anthracyclines) as induction therapy for acute mycloid leukaemia
-
The AML Collaborative Group (1998) A systematic collaborative overview of randomized trials comparing idarubicin with daunorubicin for other anthracyclines) as induction therapy for acute mycloid leukaemia. British Journal of Haematology, 101, 100-109.
-
(1998)
British Journal of Haematology
, vol.101
, pp. 100-109
-
-
-
92
-
-
85069110503
-
Treatment of relapsing acute promyelocutic leukemia (APL) by all-trans retinoic acid (ATRA) therapy followed by timed sequential chemotherapy and stem cell transplantation
-
Thomas, X., Dombret, H., Sadoun, A., Guerci, A., Cahn, J.Y., Cordonnier, C., Reman, O., Travade, P., Gratecos, N., Gardin, C., Cousin, T., Vekhoff, A., Stamatoullas, S., Fegueux, N., de Revel, T., Maloise, E., Chomienne, C., Degos, L. & Fenaux, P. (1998) Treatment of relapsing acute promyelocutic leukemia (APL) by all-trans retinoic acid (ATRA) therapy followed by timed sequential chemotherapy and stem cell transplantation. Blood 92. (Suppl. 1), 323a.
-
(1998)
Blood
, vol.92
, Issue.SUPPL. 1
-
-
Thomas, X.1
Dombret, H.2
Sadoun, A.3
Guerci, A.4
Cahn, J.Y.5
Cordonnier, C.6
Reman, O.7
Travade, P.8
Gratecos, N.9
Gardin, C.10
Cousin, T.11
Vekhoff, A.12
Stamatoullas, S.13
Fegueux, N.14
De Revel, T.15
Maloise, E.16
Chomienne, C.17
Degos, L.18
Fenaux, P.19
-
93
-
-
6844237003
-
Cost-effectiveness and quality of life assessment of GM-CSF as an adjunct to intensive remission induction chemotherapy in elderly patients with acute mycloid leukaemia
-
Uyl de Groot, C.A., Lowenberg, B., Vellenga, E., Suciu, S., Willemze, R. & Rutten, F.F. (1998) Cost-effectiveness and quality of life assessment of GM-CSF as an adjunct to intensive remission induction chemotherapy in elderly patients with acute mycloid leukaemia. British Journal of Haematology. 100, 629-636.
-
(1998)
British Journal of Haematology
, vol.100
, pp. 629-636
-
-
Uyl De Groot, C.A.1
Lowenberg, B.2
Vellenga, E.3
Suciu, S.4
Willemze, R.5
Rutten, F.F.6
-
94
-
-
0028102950
-
Therapeutic and neurotoxic effects of 2-chlorodeoxyadenosine in adults with acute mycloid leukemia
-
Vahdat, L., Wong, E.T., Wile, M.J., Rosenblum, M., Foley, K.M. & Warrell, R.P. (1994) Therapeutic and neurotoxic effects of 2-chlorodeoxyadenosine in adults with acute mycloid leukemia. Blood. 84, 3429-3434.
-
(1994)
Blood
, vol.84
, pp. 3429-3434
-
-
Vahdat, L.1
Wong, E.T.2
Wile, M.J.3
Rosenblum, M.4
Foley, K.M.5
Warrell, R.P.6
-
95
-
-
0030729284
-
MDR 1 expression is an independent prognostic factor for response and survival in de novo acute mycloid leukaemia
-
Van Den Heuvel-Eibrink, M.M., Van Der Holt, B., Te Boekhorst, P.A.W., Pieters, R., Schoester, M., Lowenberg, B. & Sonneveld, P. (1997) MDR 1 expression is an independent prognostic factor for response and survival in de novo acute mycloid leukaemia. British Journal of Haematology. 99, 76-83.
-
(1997)
British Journal of Haematology
, vol.99
, pp. 76-83
-
-
Van Den Heuvel-Eibrink, M.M.1
Van Der Holt, B.2
Te Boekhorst, P.A.W.3
Pieters, R.4
Schoester, M.5
Lowenberg, B.6
Sonneveld, P.7
-
96
-
-
0029395378
-
Donor leukocyte transfusions for leukemic relapse
-
Van Rhee, F. & Kolb, H.J. (1995) Donor leukocyte transfusions for leukemic relapse. Current Opinion in Hematology, 2, 423-430.
-
(1995)
Current Opinion in Hematology
, vol.2
, pp. 423-430
-
-
Van Rhee, F.1
Kolb, H.J.2
-
97
-
-
4243243195
-
Effect of CR on survival in patients with AML receiving first salvage therapy
-
Vey, N., Keating. M.J., Rios, M.B. & Estey, E. (1998) Effect of CR on survival in patients with AML receiving first salvage therapy. Mood. 92, (Suppl. 1). 235a.
-
(1998)
Mood
, vol.92
, Issue.SUPPL. 1
-
-
Vey, N.1
Keating, M.J.2
Rios, M.B.3
Estey, E.4
-
98
-
-
0030451886
-
Probability of long-term disease-free survival for acute mycloid leukemia patients after first relapse: A single centre experience
-
Vignetti, M., Orsini, E., Petti, M.C., Moleti, M.L., Andrizzi. C., Pinto, R.M., Amadori, S. & Meloni, G. (1996) Probability of long-term disease-free survival for acute mycloid leukemia patients after first relapse: a single centre experience. Annals of Oncology. 7, 933-938.
-
(1996)
Annals of Oncology
, vol.7
, pp. 933-938
-
-
Vignetti, M.1
Orsini, E.2
Petti, M.C.3
Moleti, M.L.4
Andrizzi, C.5
Pinto, R.M.6
Amadori, S.7
Meloni, G.8
-
99
-
-
0026650021
-
A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: A Southeastern Cancer Study Group trial
-
Vogler, W.R., Vefez-Garcia, E., Weiner, R.S., Flaum, M.A., Bartolucci, A.A., Omura, G.A., Gerber, M.C. & Banks, P.L. (1992) A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group trial. Journal of Clinical Oncology. 10, 1103-1111.
-
(1992)
Journal of Clinical Oncology
, vol.10
, pp. 1103-1111
-
-
Vogler, W.R.1
Vefez-Garcia, E.2
Weiner, R.S.3
Flaum, M.A.4
Bartolucci, A.A.5
Omura, G.A.6
Gerber, M.C.7
Banks, P.L.8
-
100
-
-
0032924997
-
Outcome for children with relapsed acute mycloid leukemia following initial therapy in the Medical Research Council (MRC) AML 10 trial
-
Webb, D.K.H., Wheatley, K., Harrison, G., Stevens, R.F. & Hann, I.M. (1999) Outcome for children with relapsed acute mycloid leukemia following initial therapy in the Medical Research Council (MRC) AML 10 trial. Leukemia, 13, 25-31.
-
(1999)
Leukemia
, vol.13
, pp. 25-31
-
-
Webb, D.K.H.1
Wheatley, K.2
Harrison, G.3
Stevens, R.F.4
Hann, I.M.5
-
101
-
-
0019861205
-
Antileukemic effect of graft-versus-host disease: Contribution to improved survival after allogeneic transplantation
-
Weiden, P.L., Sullivan, K.M. & Flournoy, N. (1981) Antileukemic effect of graft-versus-host disease: contribution to improved survival after allogeneic transplantation. New England Journal of Medicine, 304, 1529-1532.
-
(1981)
New England Journal of Medicine
, vol.304
, pp. 1529-1532
-
-
Weiden, P.L.1
Sullivan, K.M.2
Flournoy, N.3
-
102
-
-
0028132188
-
Cytosine arabinoside und mitoxantronc induction chemotherapy followed by bone marrow transplantation or chemotherapy for relapsed or refractory pediatric acute myeloid leukemia
-
Wells, R.J., Gold, S.H., Krill, C.E., Cornelius, A.S., Byrd, R.L., Ruymann, F.B., White, M.L., Feuser, J. & Cairo, M.S. (1994) Cytosine arabinoside und mitoxantronc induction chemotherapy followed by bone marrow transplantation or chemotherapy for relapsed or refractory pediatric acute myeloid leukemia. Leukemia, 8, 1626-1630.
-
(1994)
Leukemia
, vol.8
, pp. 1626-1630
-
-
Wells, R.J.1
Gold, S.H.2
Krill, C.E.3
Cornelius, A.S.4
Byrd, R.L.5
Ruymann, F.B.6
White, M.L.7
Feuser, J.8
Cairo, M.S.9
-
103
-
-
85069098147
-
A simple, robust and highly predictive prognostic index for the determination of risk-directed therapy in acute mycloid leukemia derived from the MRC AML 10 trial
-
(in press)
-
Wheatley, K., Burnett, A.K., Goldstone, A.H., Gray, R.G., Hann, I.M., Harrison, C., Rees, J.K.H., Stevens, R.F. & Walker, H. (1999) A simple, robust and highly predictive prognostic index for the determination of risk-directed therapy in acute mycloid leukemia derived from the MRC AML 10 trial. Blood (in press).
-
(1999)
Blood
-
-
Wheatley, K.1
Burnett, A.K.2
Goldstone, A.H.3
Gray, R.G.4
Hann, I.M.5
Harrison, C.6
Rees, J.K.H.7
Stevens, R.F.8
Walker, H.9
-
104
-
-
0031052815
-
High-dose cytosine arabinoside and etoposide: An effective regimen without anthracyclines for refractory childhood acute non-lymphocytic leukemia
-
Whitlock, J.A., Wells, R.J., Hord, J.D., Janco, R.L., Greer, J.P., Gay, J.C., Edwards, J.R., McCurley, T.L. & Lukens, J.N. (1997) High-dose cytosine arabinoside and etoposide: an effective regimen without anthracyclines for refractory childhood acute non-lymphocytic leukemia, Leukemia, 11, 185-189.
-
(1997)
Leukemia
, vol.11
, pp. 185-189
-
-
Whitlock, J.A.1
Wells, R.J.2
Hord, J.D.3
Janco, R.L.4
Greer, J.P.5
Gay, J.C.6
Edwards, J.R.7
McCurley, T.L.8
Lukens, J.N.9
-
105
-
-
0031452589
-
The prognostic significance of the epxression and function of multidrug resistance proteins in acute myeloid leukemia: Studies of the Southwest Oncology Group Leukemia Research Program
-
Willman, C.L., (1997) The prognostic significance of the epxression and function of multidrug resistance proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program. Seminars in Hematology. 34, (Suppl. 5), 25-33.
-
(1997)
Seminars in Hematology
, vol.34
, Issue.SUPPL. 5
, pp. 25-33
-
-
Willman, C.L.1
-
106
-
-
0028244591
-
P-glycoprotein expression on acute myeloid leukaemia blast cells at diagnosis predicts response to chemotherapy and survival
-
Wood, P., Burgess, R., MacGregor. A. & Liu Yin, J.A. (1994) P-glycoprotein expression on acute myeloid leukaemia blast cells at diagnosis predicts response to chemotherapy and survival. British Journal of Haematology. 87, 509-514.
-
(1994)
British Journal of Haematology
, vol.87
, pp. 509-514
-
-
Wood, P.1
Burgess, R.2
Macgregor, A.3
Liu Yin, J.A.4
-
107
-
-
8944249286
-
Timed sequential induction therapy improves postremission outcome in acute myeloid leukemia: A report from the Children's Cancer Group
-
Woods, W.G., Kobrinsky, N., Buckley, J.D., Lee, J.W., Sanders, J., Neudorf, S., Cold, S., Barnard, D.R., DeSwarte, J., Dusenbery, K., Kalousek, D. & Arthur, D.C. (1996) Timed sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group. Blood. 67, 4979-4989.
-
(1996)
Blood
, vol.67
, pp. 4979-4989
-
-
Woods, W.G.1
Kobrinsky, N.2
Buckley, J.D.3
Lee, J.W.4
Sanders, J.5
Neudorf, S.6
Cold, S.7
Barnard, D.R.8
Deswarte, J.9
Dusenbery, K.10
Kalousek, D.11
Arthur, D.C.12
-
108
-
-
0029922321
-
Levels of mdr1 and mrp mRNA in leukaemic cell populations from patients with acute myelocytic leukaemia are heterogenous and inversely correlated to cellular daunorubicin accumulation
-
Xu, D., Knaust, K., Pisa, P., Palucka, K., Lundeberg, J., Arestrom, I., Peterson, O. & Gruber, A. (1996) levels of mdr1 and mrp mRNA in leukaemic cell populations from patients with acute myelocytic leukaemia are heterogenous and inversely correlated to cellular daunorubicin accumulation. British Journal of Haematology. 92, 847-854.
-
(1996)
British Journal of Haematology
, vol.92
, pp. 847-854
-
-
Xu, D.1
Knaust, K.2
Pisa, P.3
Palucka, K.4
Lundeberg, J.5
Arestrom, I.6
Peterson, O.7
Gruber, A.8
-
109
-
-
0026720403
-
Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia
-
Yeager, A.M., Vogelsang, G.B., Jones, R.J., Farmer, E.R., Altomonte, V., Hess, A.D. & Santos, G.W. (1992) Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia. Blood. 79, 3031-3035.
-
(1992)
Blood
, vol.79
, pp. 3031-3035
-
-
Yeager, A.M.1
Vogelsang, G.B.2
Jones, R.J.3
Farmer, E.R.4
Altomonte, V.5
Hess, A.D.6
Santos, G.W.7
-
110
-
-
0003254672
-
Comparison of two chemotherapy regimens with or without cyclosporin A, in relapsed/refractory acute myeloid leukaemia: Results of the UK Medical Research Council AML-R trial
-
Yin, J.A.L., Wheatley, K., Rees, J. & Burnett, A.J. (1998) Comparison of two chemotherapy regimens with or without cyclosporin A, in relapsed/refractory acute myeloid leukaemia: results of the UK Medical Research Council AML-R trial. Blood, 92, (Suppl. 1). 231a.
-
(1998)
Blood
, vol.92
, Issue.SUPPL. 1
-
-
Yin, J.A.L.1
Wheatley, K.2
Rees, J.3
Burnett, A.J.4
|